UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2025
Commission File No.: 000-30668
Commission File No.: 000-30668
NOVA LTD.
(Translation of registrant’s name into English)
5 David Fikes Street, Rehovot, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Attached hereto and incorporated by way of reference herein is a press release issued by the Registrant and entitled: “Nova Reports Record Fourth Quarter and Full Year 2024 Results”.
The GAAP financial statements tables included in the press release attached hereto are hereby incorporated by reference into the Registrant’s registration statements on Form S-8,
filed with the Securities and Exchange Commission on the following dates: November 5, 2007 (File No. 333-147140); October 25, 2012 (File No. 333-184585), March 6, 2015 (File No. 333-202550); and August 25, 2017 (File No. 333-220158).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: February 13, 2025
|
|
NOVA LTD.
(Registrant) By: /s/ Guy Kizner ————————————— Guy Kizner
Chief Financial Officer |
Company Contact:
Guy Kizner, Chief Financial Officer
Tel: +972-73-229-5760
E-mail - [email protected]
Nova website link - https://www.novami.com/
Investor Relations Contact:
Miri Segal MS-IR LLC
Tel: +917-607-8654
E-mail - [email protected]
Nova Reports Record Fourth Quarter and Full Year 2024 Results
REHOVOT, Israel - February 13, 2025 - Nova (Nasdaq: NVMI) today announced financial results for the fourth
quarter and full year ended December 31, 2024.
Fourth Quarter 2024 Highlights:
| • |
Record Quarterly revenue of $194.8 million, a 9% QoQ increase, exceeding the Company guidance and up 45% YoY.
|
| • |
GAAP net income of $50.5 million, or $1.58 per diluted share, up 32% YoY.
|
| • |
Record non-GAAP net income of $62.3 million, or $1.94 per diluted share, exceeding the Company guidance, and up 43% YoY.
|
| • |
Record sales of materials metrology, driven by sales of Nova Metrion and Nova Veraflex platforms
|
| • |
Record sales for dimensional metrology stand-alone solutions, driven by demand for unique capabilities in advanced packaging and GAA manufacturing.
|
Full Year 2024 Highlights:
| • |
Record annual revenue of $672.4 million up 30% YoY
|
| • |
Record GAAP net income of $183.8 million, or $5.75 per diluted share up 34% YoY
|
| • |
Record Non-GAAP net income of $214.9 million, or $6.69 per diluted share up 38% YoY
|
| • |
Record sales for advanced packaging processes, more than doubling revenues from the segment
|
| • |
Record sales of materials metrology, driven by growing adoption of the Company’s solutions across market segments
|
GAAP Results (K)
|
Q4 2024
|
Q3 2024
|
Q4 2023
|
FY 2024
|
FY 2023
|
|
|
Revenues
|
$194,766
|
$178,974
|
$134,219
|
$672,396
|
$517,922
|
|
Net Income
|
$50,481
|
$51,279
|
$38,068
|
$183,762
|
$136,310
|
|
Earnings per Diluted Share
|
$1.58
|
$1.60
|
$1.20
|
$5.75
|
$4.28
|
Non-GAAP Results (K)
|
Q4 2024
|
Q3 2024
|
Q4 2023
|
FY 2024
|
FY 2023
|
|
|
Net Income
|
$62,302
|
$56,056
|
$43,597
|
$214,926
|
$155,891
|
|
Earnings per Diluted Share
|
$1.94
|
$1.74
|
$1.36
|
$6.69
|
$4.86
|
A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements
included in this release. See also "Use of Non-GAAP Adjusted Financial Measures" section.
Management Comments
“Nova continues to outperform the market, with quarterly and annual sales records which exceeded the high end of the guidance in both revenue and
profitability,” said Gaby Waisman, President and CEO. “As we reflect on the past year, we count multiple achievements across our product lines, including strategic penetrations into leading manufacturers, an evolving position in new segments, and a
growing market share. All of these, combined with Nova’s long-term strategy for perpetual growth, set the stage for our continued growth in 2025.”
2025 First Quarter Financial Outlook
Management provided an outlook for the first quarter, the period ending March 31, 2025. Based on current estimates, management expects:
| • |
$205 million to $215 million in revenue
|
| • |
$1.75 to $1.91 in diluted GAAP EPS
|
| • |
$2.00 to $2.16 in diluted non-GAAP EPS
|
2024 Fourth Quarter Results
Total revenues for the fourth quarter of 2024 were $194.8 million, an increase of 9% compared with the third quarter of 2024 and an increase of 45%
compared with the fourth quarter of 2023.
Gross margin in the fourth quarter of 2024 was 56.4%, compared with 56.6% in the third quarter of 2024 and 55.1% in the fourth quarter of 2023.
Operating expenses in the fourth quarter of 2024 were $54.5 million, compared with $52.1 million in the third quarter of 2024 and $40.4 million in the
fourth quarter of 2023.
On a GAAP basis, the Company reported net income of $50.5 million, or $1.58 per diluted share, in the fourth quarter of 2024. This is compared with net
income of $51.3 million, or $1.60 per diluted share, in the third quarter of 2024, and $38.1 million, or $1.20 per diluted share, in the fourth quarter of 2023.
On a non-GAAP basis, the Company reported net income of $ 62.3 million, or $1.94 per diluted share, in the fourth quarter of 2024. This is compared with
net income of $ 56.1 million, or $1.74 per diluted share, in the third quarter of 2024, and $43.6 million, or $1.36 per diluted share, in the fourth quarter of 2023.
2024 Full Year Results
Total revenues for 2024 were $672.4 million, an increase of 30% compared to total revenues of $517.9 million for 2023.
Gross margin in 2024 was 57.6%, compared with 56.6% in 2023.
Operating expenses in 2024 were $199.5 million, compared with operating expenses of $160.9 million in 2023.
On a GAAP basis, the Company reported net income of $183.7 million, or $5.75 per diluted share, in 2024. This is compared with a net income of $136.3
million, or $4.28 per diluted share, in 2023.
On a non-GAAP basis, the Company reported net income of $214.9 million, or $6.69 per diluted share, in 2024. This is compared with net income of $155.9
million, or $4.86 per diluted share, in 2023.
Conference Call Information
Nova will host a conference call today, February 13, 2025, at 8:30 a.m. Eastern Time, to discuss the Company’s fourth quarter 2024 financial results and
outlook. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your calls five minutes before the conference call commences. If you are unable to connect using the toll-free numbers,
please try the international dial-in number.
U.S. TOLL-FREE Dial-in Number: 1-833-816-1427
ISRAEL TOLL-FREE Dial-in Number: 1-809-213-284
INTERNATIONAL Dial-in Number: 1-412-317-0519
At:
8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
3:30 p.m. Israel Time
The conference call will also be webcast live from a Link on Nova's website at https://www.novami.com/investors/events/.
A replay of the conference call will be available from February 13, 2025, at 11:30 a.m. Eastern Time until August 15, 2025, at 11:59 p.m. Eastern Time.
To access the replay, please dial one of the following numbers:
Replay Dial-in U.S. TOLL-FREE: 1-877-344-7529
Replay Dial-in INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 8533745
A replay will also be available for 90 days on Nova's website link at https://www.novami.com/investors/events/.
About Nova
Nova is a leading innovator and key provider of material, optical and chemical metrology solutions for advanced process control in semiconductor
manufacturing. Nova delivers continuous innovation by providing state-of-the-art, high-performance metrology solutions for effective process control throughout the semiconductor fabrication lifecycle. Nova’s product portfolio, which combines
high-precision hardware and cutting-edge software, provides its customers with deep insight into developing and producing the most advanced semiconductor devices. Nova’s unique capability to deliver innovative solutions enables its customers to
improve performance, enhance product yields and accelerate time to market. Nova acts as a partner to semiconductor manufacturers from its offices worldwide. Additional information may be found on Nova’s website link -
https://www.novami.com/.
Nova is traded on the Nasdaq and TASE, Nasdaq ticker symbol NVMI.
Use of Non-GAAP Adjusted Financial Measures
This press release provides financial measures that exclude amortization of acquired intangible assets, stock-based compensation expenses, acquisition
related expenses, revaluation of operating lease liabilities and remeasurement of intercompany loans, amortization of issuance costs and tax effect of non-GAAP adjustment, as applicable, and are therefore not calculated in accordance with generally
accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding Nova's performance because they reflect our operational results and enhance management's and
investors' ability to evaluate Nova's performance before charges or benefits considered by management to be outside Nova's ongoing operating results. The presentation of this non-GAAP financial information is not intended to be considered in
isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management believes that it is in the best interest of its investors to provide financial information that will facilitate comparison of both
historical and future results and allow greater transparency to supplemental information used by management in its financial and operational decision making. A reconciliation of each GAAP to non-GAAP financial measure discussed in this press
release is contained in the accompanying financial tables.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of
1995 relating to future events or our future performance, such as statements regarding, but not limited to, anticipated growth opportunities and projections about our business and its future revenues, expenses and profitability. Forward-looking
statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or
achievements expressed or implied in those forward-looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: increased information technology security
threats and sophisticated computer crime; foreign political and economic risks including supply-chain difficulties; regulations that could restrict our operations such as economic sanctions and export restrictions; changes in U.S. trade policies;
indirect effects of the Russia – Ukraine conflict; market instability including inflation and recessionary pressures; risks related to doing business with China; catastrophic events; inability to protect our intellectual property; open source
technology exposure, including risks related to artificial intelligence; failure to compete effectively or to respond to rapid technological changes; consolidation in our industry; difficulty in predicting the length and strength of any downturn or
expansion period of the market we target; factors that adversely affect the pricing and demand for our product lines; dependency on a small number of large customers; dependency on a single manufacturing facility per product line; dependency on a
limited number of suppliers; difficulty in integrating current or future acquisitions; lengthy sales cycle and customer delays in orders; risks related to conditions in Israel, including related to the war against Hamas and other terrorist
organizations; risks related to our convertible notes; currency fluctuations; and quarterly fluctuations in our operating results. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this
press release also involve risks and uncertainties summarized under the heading "Risk Factors" in Nova's Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission on February 20, 2024. These
factors are updated from time to time through the filing of reports and registration statements with the Securities and Exchange Commission. Nova Ltd. does not assume any obligation to update the forward-looking information contained in this press
release.
(Tables to Follow)
NOVA LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands) - (Unaudited)
|
As of December 31,
|
||||||||
|
|
2024
|
2023
|
||||||
| ASSETS |
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
157,779
|
107,574
|
||||||
|
Short-term interest-bearing bank deposits
|
211,877
|
119,850
|
||||||
|
Marketable securities
|
216,910
|
216,258
|
||||||
|
Trade accounts receivable, net
|
139,318
|
111,256
|
||||||
|
Inventories
|
156,599
|
138,198
|
||||||
|
Other current assets
|
19,466
|
17,084
|
||||||
|
Total current assets
|
901,949
|
710,220
|
||||||
|
Non-current assets
|
||||||||
|
Marketable securities
|
225,818
|
191,351
|
||||||
|
Interest-bearing bank deposits and restricted deposits
|
7,847
|
6,254
|
||||||
|
Deferred tax assets
|
31,639
|
23,583
|
||||||
|
Operating lease right-of-use assets
|
51,193
|
41,856
|
||||||
|
Property plant and equipment, net
|
81,746
|
66,874
|
||||||
|
Intangible assets, net
|
31,458
|
39,184
|
||||||
|
Goodwill
|
48,317
|
50,080
|
||||||
|
Other long-term assets
|
10,455
|
4,405
|
||||||
|
Total non-current assets
|
488,473
|
423,587
|
||||||
|
Total assets
|
1,390,422
|
1,133,807
|
||||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Current liabilities
|
||||||||
|
Convertible senior notes, net
|
180,564
|
197,678
|
||||||
|
Trade accounts payable
|
59,578
|
35,158
|
||||||
|
Deferred revenues
|
72,886
|
41,978
|
||||||
|
Operating lease current liabilities
|
7,169
|
6,703
|
||||||
|
Other current liabilities
|
68,033
|
41,294
|
||||||
|
Total current liabilities
|
388,230
|
322,811
|
||||||
|
Non-current liabilities
|
||||||||
|
Operating lease long-term liabilities
|
48,363
|
39,762
|
||||||
|
Long-term deferred tax liability
|
8,495
|
10,574
|
||||||
|
Other long-term liabilities
|
17,539
|
9,908
|
||||||
|
Total non-current liabilities
|
74,397
|
60,244
|
||||||
|
Shareholders' equity
|
927,795
|
750,752
|
||||||
|
Total liabilities and shareholders' equity
|
1,390,422
|
1,133,807
|
||||||
NOVA LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(U.S. dollars in thousands, except per share data) - (Unaudited)
|
Three months ended
December 31,
|
Year ended
December 31,
|
|||||||||||||||
|
2024
|
2023
|
2024
|
2023
|
|||||||||||||
|
Revenues:
|
||||||||||||||||
|
Products
|
158,546
|
104,108
|
538,350
|
405,037
|
||||||||||||
|
Services
|
36,220
|
30,111
|
134,046
|
112,885
|
||||||||||||
|
Total revenues
|
194,766
|
134,219
|
672,396
|
517,922
|
||||||||||||
|
Total cost of revenues
|
84,835
|
60,207
|
285,310
|
224,745
|
||||||||||||
|
Gross profit
|
109,931
|
74,012
|
387,086
|
293,177
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development, net
|
30,909
|
21,290
|
110,257
|
88,043
|
||||||||||||
|
Sales and marketing
|
15,980
|
13,580
|
65,090
|
52,467
|
||||||||||||
|
General and administrative
|
7,571
|
5,480
|
24,199
|
20,404
|
||||||||||||
|
Total operating expenses
|
54,460
|
40,350
|
199,546
|
160,914
|
||||||||||||
|
Operating income
|
55,471
|
33,662
|
187,540
|
132,263
|
||||||||||||
|
Financing income, net
|
3,756
|
7,283
|
28,747
|
22,436
|
||||||||||||
|
Income before taxes on income
|
59,227
|
40,945
|
216,287
|
154,699
|
||||||||||||
|
Income tax expenses
|
8,746
|
2,877
|
32,525
|
18,389
|
||||||||||||
|
Net income for the period
|
50,481
|
38,068
|
183,762
|
136,310
|
||||||||||||
|
Earnings per share:
|
||||||||||||||||
|
Basic
|
1.72
|
1.31
|
6.31
|
4.73
|
||||||||||||
|
Diluted
|
1.58
|
1.20
|
5.75
|
4.28
|
||||||||||||
|
Shares used in calculation of earnings per share
(in thousands): |
||||||||||||||||
|
Basic
|
29,304
|
28,975
|
29,113
|
28,828
|
||||||||||||
|
Diluted
|
32,062
|
32,023
|
32,138
|
32,089
|
||||||||||||
NOVA LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(U.S. dollars in thousands) - (Unaudited)
|
Three months ended
December 31,
|
Year ended
December 31,
|
|||||||||||||||
|
2024
|
2023
|
2024
|
2023
|
|||||||||||||
|
Cash flows from operating activities:
|
||||||||||||||||
|
Net income
|
50,481
|
38,068
|
183,762
|
136,310
|
||||||||||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||||||||||
|
Depreciation of property and equipment
|
3,029
|
2,756
|
11,736
|
10,344
|
||||||||||||
|
Amortization of intangible assets
|
1,267
|
1,461
|
5,643
|
5,857
|
||||||||||||
|
Amortization of premium and accretion of discount on marketable securities, net
|
(1,820
|
)
|
(1,134
|
)
|
(7,178
|
)
|
(3,001
|
)
|
||||||||
|
Amortization of debt issuance costs
|
310
|
324
|
1,280
|
1,284
|
||||||||||||
|
Share-based compensation
|
6,349
|
5,654
|
25,209
|
18,286
|
||||||||||||
|
Net effect of exchange rate fluctuation
|
4,109
|
(2,591
|
)
|
3,025
|
1,754
|
|||||||||||
|
Changes in assets and liabilities:
|
||||||||||||||||
|
Trade accounts receivable, net
|
(26,196
|
)
|
(18,606
|
)
|
(29,051
|
)
|
(1,183
|
)
|
||||||||
|
Inventories
|
876
|
2,851
|
(23,897
|
)
|
(26,000
|
)
|
||||||||||
|
Other current and long-term assets
|
(4,097
|
)
|
(361
|
)
|
(9,671
|
)
|
(5,752
|
)
|
||||||||
|
Deferred tax, net
|
(4,849
|
)
|
(185
|
)
|
(9,722
|
)
|
(6,241
|
)
|
||||||||
|
Operating lease right-of-use assets
|
559
|
259
|
3,668
|
3,050
|
||||||||||||
|
Trade accounts payable
|
6,309
|
8,917
|
17,506
|
(7,807
|
)
|
|||||||||||
|
Deferred revenues
|
19,494
|
(292
|
)
|
34,553
|
11,391
|
|||||||||||
|
Operating lease liabilities
|
97
|
2,091
|
(3,938
|
)
|
(3,221
|
)
|
||||||||||
|
Other current and long-term liabilities
|
12,686
|
(9,671
|
)
|
32,299
|
(11,352
|
)
|
||||||||||
|
Accrued severance pay, net
|
(82
|
)
|
64
|
42
|
(188
|
)
|
||||||||||
|
Net cash provided by operating activities
|
68,522
|
29,605
|
235,266
|
123,531
|
||||||||||||
|
Cash flows from investment activities:
|
||||||||||||||||
|
Change in short-term and long-term interest-bearing bank deposits
|
(4,339
|
)
|
31,367
|
(93,595
|
)
|
(29,658
|
)
|
|||||||||
|
Investment in marketable securities
|
(60,175
|
)
|
(106,695
|
)
|
(271,987
|
)
|
(273,572
|
)
|
||||||||
|
Proceeds from maturity of marketable securities
|
57,421
|
44,443
|
246,397
|
195,087
|
||||||||||||
|
Purchase of property and equipment
|
(8,121
|
)
|
(7,601
|
)
|
(17,215
|
)
|
(17,188
|
)
|
||||||||
|
Net cash used in investing activities
|
(15,214
|
)
|
(38,486
|
)
|
(136,400
|
)
|
(125,331
|
)
|
||||||||
|
Cash flows from financing activities:
|
||||||||||||||||
|
Purchases of treasury shares
|
(30,000
|
)
|
-
|
(30,000
|
)
|
(112
|
)
|
|||||||||
|
Conversion of convertible senior notes
|
(18,506
|
)
|
-
|
(18,506
|
)
|
-
|
||||||||||
|
Proceeds from exercise of options
|
90
|
-
|
160
|
122
|
||||||||||||
|
Net cash provided by financing activities
|
(48,416
|
)
|
-
|
(48,346
|
)
|
10
|
||||||||||
|
Effect of exchange rate fluctuations on cash and cash equivalents
|
(1,076
|
)
|
(25
|
)
|
(315
|
)
|
(2,357
|
)
|
||||||||
|
Changes in cash and cash equivalents and restricted cash
|
3,816
|
(8,906
|
)
|
50,205
|
(4,147
|
)
|
||||||||||
|
Cash and cash equivalents and restricted cash -beginning of period
|
153,963
|
116,480
|
107,574
|
111,721
|
||||||||||||
|
Cash and cash equivalents - end of period
|
157,779
|
107,574
|
157,779
|
107,574
|
||||||||||||
NOVA LTD.
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(U.S. dollars in thousands, except percentage and per share data) - (Unaudited)
|
Three months ended
|
||||||||||||
|
December 31,
2024 |
September 30,
2024 |
December 31,
2023 |
||||||||||
|
GAAP gross profit
|
109,931
|
101,333
|
74,012
|
|||||||||
|
Stock-based compensation*
|
1,805
|
1,722
|
1,537
|
|||||||||
|
Amortization of acquired intangible assets
|
1,182
|
1,380
|
1,354
|
|||||||||
|
Non-GAAP gross profit
|
112,918
|
104,435
|
76,903
|
|||||||||
|
GAAP gross margin as a percentage of revenues
|
56
|
%
|
57
|
%
|
55
|
%
|
||||||
|
Non-GAAP gross margin as a percentage of revenues
|
58
|
%
|
58
|
%
|
57
|
%
|
||||||
|
GAAP operating income
|
55,471
|
49,231
|
33,662
|
|||||||||
|
Stock-based compensation*
|
6,349
|
6,194
|
5,654
|
|||||||||
|
Acquisition related expenses
|
917
|
-
|
-
|
|||||||||
|
Amortization of acquired intangible assets
|
1,267
|
1,467
|
1,461
|
|||||||||
|
Non-GAAP operating income
|
64,004
|
56,892
|
40,777
|
|||||||||
|
GAAP operating margin as a percentage of revenues
|
28
|
%
|
28
|
%
|
25
|
%
|
||||||
|
Non-GAAP operating margin as a percentage of revenues
|
33
|
%
|
32
|
%
|
30
|
%
|
||||||
|
GAAP net income
|
50,481
|
51,279
|
38,068
|
|||||||||
|
Stock-based compensation*
|
6,349
|
6,194
|
5,654
|
|||||||||
|
Acquisition related expenses
|
917
|
-
|
-
|
|||||||||
|
Amortization of acquired intangible assets
|
1,267
|
1,467
|
1,461
|
|||||||||
|
Amortization of debt issuance costs
|
310
|
326
|
324
|
|||||||||
|
Revaluation of operating lease and intercompany loans
|
4,706
|
(2,309
|
)
|
(827
|
)
|
|||||||
|
Tax effect of non-GAAP adjustments
|
(1,728
|
)
|
(901
|
)
|
(1,083
|
)
|
||||||
|
Non-GAAP net income
|
62,302
|
56,056
|
43,597
|
|||||||||
|
GAAP basic earnings per share
|
1.72
|
1.76
|
1.31
|
|||||||||
|
Non-GAAP basic earnings per share
|
2.13
|
1.93
|
1.50
|
|||||||||
|
GAAP diluted earnings per share
|
1.58
|
1.60
|
1.20
|
|||||||||
|
Non-GAAP diluted earnings per share
|
1.94
|
1.74
|
1.36
|
|||||||||
|
Shares used for calculation of earnings per share
(in thousands): |
||||||||||||
|
Basic
|
29,304
|
29,099
|
28,975
|
|||||||||
|
Diluted
|
32,062
|
32,238
|
32,023
|
|||||||||
* Stock-based compensation for the three months ended December 31, 2024 included in - Cost of revenues - 1,805; Research and development, net - 2,747; Sales and marketing - 1,234; General and administrative - 563.
NOVA LTD.
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(U.S. dollars in thousands, except percentage and per share data) - (Unaudited)
|
Year ended December 31,
|
||||||||
|
2024
|
2023
|
|||||||
|
GAAP gross profit
|
387,086
|
293,177
|
||||||
|
Stock-based compensation*
|
7,013
|
4,946
|
||||||
|
Acquisition-related inventory step-up
|
5,284
|
5,430
|
||||||
|
Non-GAAP gross profit
|
399,383
|
303,553
|
||||||
|
GAAP gross margin as a percentage of revenues
|
58
|
%
|
57
|
%
|
||||
|
Non-GAAP gross margin as a percentage of revenues
|
59
|
%
|
59
|
%
|
||||
|
GAAP operating income
|
187,540
|
132,263
|
||||||
|
Stock-based compensation*
|
25,209
|
18,286
|
||||||
|
Acquisition related expenses
|
917
|
-
|
||||||
|
Amortization of acquired intangible assets
|
5,643
|
5,857
|
||||||
|
Non-GAAP operating income
|
219,309
|
156,406
|
||||||
|
GAAP operating margin as a percentage of revenues
|
28
|
%
|
26
|
%
|
||||
|
Non-GAAP operating margin as a percentage of revenues
|
33
|
%
|
30
|
%
|
||||
|
GAAP net income
|
183,762
|
136,310
|
||||||
|
Stock-based compensation*
|
25,209
|
18,286
|
||||||
|
Acquisition related expenses
|
917
|
-
|
||||||
|
Amortization of acquired intangible assets
|
5,643
|
5,857
|
||||||
|
Amortization of debt issuance costs
|
1,280
|
1,284
|
||||||
|
Revaluation of operating lease liabilities
|
3,221
|
(1,994
|
)
|
|||||
|
Tax effect of non-GAAP adjustments
|
(5,106
|
)
|
(3,852
|
)
|
||||
|
Non-GAAP net income
|
214,926
|
155,891
|
||||||
|
GAAP basic earnings per share
|
6.31
|
4.73
|
||||||
|
Non-GAAP basic earnings per share
|
7.38
|
5.41
|
||||||
|
GAAP diluted earnings per share
|
5.75
|
4.28
|
||||||
|
Non-GAAP diluted earnings per share
|
6.69
|
4.86
|
||||||
|
Shares used for calculation of earnings per share
(in thousands): |
||||||||
|
Basic
|
29,113
|
28,828
|
||||||
|
Diluted
|
32,138
|
32,089
|
||||||
* Stock-based compensation for the year ended December 31, 2024, included in - Cost of revenues – 7,013; Research and development, net – 11,179; Sales and marketing – 4,864; General and administrative - 2,153.
NOVA LTD.
SUPPLEMENTAL INFORMATION - RECONCILIATION OF FIRST QUARTER 2025
GAAP TO NON-GAAP GUIDANCE
SUPPLEMENTAL INFORMATION - RECONCILIATION OF FIRST QUARTER 2025
GAAP TO NON-GAAP GUIDANCE
(U.S. dollars) (Unaudited)
|
Low
|
High
|
|||||||
|
Estimated GAAP net income per diluted share
|
1.75
|
1.91
|
||||||
|
Estimated non-GAAP items:
|
||||||||
|
Stock-based compensation
|
0.19
|
0.19
|
||||||
|
Amortization of acquired intangible assets and inventory step-up
|
0.07
|
0.07
|
||||||
|
Acquisition related expenses
|
0.02
|
0.02
|
||||||
|
Amortization of issuance costs
|
0.01
|
0.01
|
||||||
|
Tax effect of non-GAAP adjustments
|
(0.04
|
)
|
(0.04
|
)
|
||||
|
Estimated non-GAAP net income per diluted share
|
2.00
|
2.16
|
||||||